IL6 and chronic kidney disease: Esgalhado and colleagues studied the effect of digestion-resistant starch supplementation (16 g/day) in patients with CKD; they observed a reduction in the plasma levels of uremic toxins (indoxyl sulfate, and p-cresyl sulfate), interleukin (IL)-6, and thiobarbituric acid-reactive substances (107).